Results: The average BDI score and PSQI score of the CAPD patients were 12.1 AE 7.9 and 6.6 AE 4.0, with 23(40.4%) depressed patients (BDI score > OR Z 16) and 37 (64.9%) poor sleepers (PSQI scores > OR Z 5). In univariate analysis, the BDI score was positively correlated with serum b2 microglobulin (r Z 0.255, P Z 0.011) and Peritoneal Kt/Vurea (r Z 6.289, P Z 0.038), While the PSQI score was negatively correlated with serum albumin (r Z À0.333, P Z 0.007) and positively correlated with high-sensitivity C-reactive protein (r Z 0.014, P Z 0.016), duration on CAPD (r Z 0.084, P Z 0.009), serum creatinine (r Z 0.005, P Z 0.013), serum phosphate (r Z 2.186, P Z 0.034), serum b2 microglobulin (r Z 0.184, P < 0.01) and Peritoneal Kt/Vurea (r Z 3.409, P Z 0.018). In multiple analysis, high serum b2 microglobulin (b Z 0.301, P Z 0.010) was the independent predictor of depression in CAPD patients, and long duration on CAPD (b Z 0.129, P Z 0.003) was the only risk factor for sleep disturbance in CAPD patients. Conclusion: Depression and sleep disturbance are common in Chinese CAPD patients. Close relationships exist between serum b2 microglobulin and depression, duration on CAPD and poor sleep quality. http://dx.
Objective: Cast nephropathy in multiple myeloma is a consequence of high serum levels of immunoglobulin free light chains (FLC). Excess monoclonal FLC results in obstructing intratubular cast formation and tubular toxicity causing acute kidney injury (AKI). This study aims to investigate the efficacy of serum FLC removal by high cut-off haemodialysis (HCO-HD) in patients with cast nephropathy. Methods: From 9/2012-9/2013, 3 patients (patients 1, 2 and 3) with dialysisdependent AKI secondary to biopsy-proven cast nephropathy were started on HCO-HD. All were Chinese; 2 females, 1 male, with mean age 65.3 years. Ultraflux EMiC2 dialyzer (polysulfone, surface area 1.8m 2 , cut-off 40kDa, albumin sieving coefficient 0.01, Fresenius Medical Care, Germany) was used. Pre-&post-HCO-HD serum FLC and albumin levels were retrospectively reviewed. Results: Patient 1 had IgA-lambda myeloma with high serum lambda FLC level and patients 2 and 3 had kappa light chain myeloma with high serum kappa FLC level. Their mean serum creatinine level on presentation was 755 mmol/L and serum FLC levels of patients 1, 2 and 3 were 14,800, 12,231 and 11,200 mg/L respectively. All patients were treated with 6 daily sessions of extended HCO-HD, 8 hours/session with blood flow rate 150e200 ml/min. Bortezomib-based chemotherapy was started on the day of 2nd HD session in patient 1 and 5th HD session in patient 2, and 1 day before HCO-HD in patient 3. The mean % reduction of serum FLC level after each HD session in patients 1, 2 and 3 were 17.8%, 73.7% and 57.9%, and the % reduction after 6 sessions of HCO-HD were 55.7%, 88.3% and 85.4% respectively. Albumin infusion of 20e220 g during the 6 HCO-HD sessions was required and there was no decrease in serum albumin post-HCO-HD. 1/3 patients (patient 1) became dialysis independent after HCO-HD. Conclusion: High cut-off hemodialysis using Ultraflux EMiC2 dialyzer combined with bortezomib-based chemotherapy effectively removes serum FLC in patients with cast nephropathy. Further prospective studies are needed to assess whether HCO-HD can improve renal or patient survival. High glucose (HG) induced epithelial-mesenchymal transition (EMT) of primary human peritoneal mesothelial cells (HPMCs) is characterized by markers, as E-cadherin and claudins. Our previous study showed that serum response factor (SRF), a transcription factor that binds to CArG boxes, is a major regulator of HPMCs EMT and fibrosis. However, the target and pathway of SRF in PD process has not to be elucidated. All these immortal HPMCs were characterized by phenotype markers and tested the expression of SRF and miRNA-199a/214 cluster by real time PCR and Western blot. Our study showed that a series of miRNAs, such as miR-214/miR-199a-5p cluster from selected primary HPMCs miRNA array and have CArG element in the promotor, were found to be regulated by SRF. ChIP and luciferase reporter assays revealed that nuclear translocation of SRF directly promotes the transcription of miR-214 and miR-199a-5p, which are examined to be highly expressed in HGinduced HPMCs. Depletion of miR-214/miR-199a cluster in HPMCs reduces EMT marking by up-regulating E-cadherin, claudins and downregulating a-SMA in vitro. Mechanistically, miR-199a-5p and miR-214 were characterized to target the E-cadherin and claudin-2 messenger RNA CDH1 and CLDN2 to contribute to the epithelial-mesenchymal transition (EMT). Together, this study reveals a novel function of SRF in HPMCs EMT and fibrosis and identified a new SRF-miR-199a/miR-214 cluster-CDH1/CLDN2 EMT axis which highlights the potential association between TFs and miRNA-mediated EMT and fibrosis in PD.
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